000			02141nam a22003735i 4500
001			234905
003			ES-VaUE
005			20221220020632.0
007			cr nn 008mamaa
008			100301s1989 xxu| s |||| 0|eng d
020			_a9781592596171
024	7		_a10.1385/0896031225 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
245	1	0	_aDrugs as Tools in Neurotransmitter Research _cedited by Alan A. Boulton, Glen B. Baker, Augusto V. Juorio.
250			_a1st edition 1989
264		1	_aTotowa, NJ _bHumana Press _c1989
300			_a1 recurso en línea (XVIII, 512 páginas) _b
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aNeuromethods _x1940-6045 _v12
505	0		_aNeurotoxins That Affect Central and Peripheral Catecholamine Neurons -- Neurotoxins that affect central indoleamine neurons -- Toxins Affecting Cholinergic Neurons -- GABA Antagonists -- Specificity of Drugs as Tools in Psychopharmacology -- Determination of Monoamine Turnover by Blockade of Their Synthesis or Metabolism -- Dopamine Receptors and Neuroleptic Drugs -- Use of 5-HT Receptor Agonists and Antagonists for the Characterization of Their Respective Receptor Sites -- Biochemical Models of Parkinson's Disease -- Drug-Induced Behavioral Models of Central Disorders -- Determination of Acetylcholine Dynamics.
700	1		_aBoulton, Alan A _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aBaker, Glen B _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aJuorio, Augusto V _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9781489941053
776	0	8	_iPrinted edition: _z9780896031227
776	0	8	_iPrinted edition: _z9781489941046
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/0896031225 _z(usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
988			_aSpringer_Protocols_1989
999			_c234905 _d234905